What is a stock summary page? Click here for an overview.
Business Description
NanoVibronix Inc
NAICS : 334510
SIC : 3842
ISIN : US63008J6038
Description
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.36 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -20.58 | |||||
| Beneish M-Score | 5.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.7 | |||||
| 3-Year EBITDA Growth Rate | 36.8 | |||||
| 3-Year EPS without NRI Growth Rate | 38.7 | |||||
| 3-Year FCF Growth Rate | 32 | |||||
| 3-Year Book Growth Rate | -4.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.99 | |||||
| 9-Day RSI | 38.59 | |||||
| 14-Day RSI | 41.74 | |||||
| 3-1 Month Momentum % | -18.8 | |||||
| 6-1 Month Momentum % | -20.59 | |||||
| 12-1 Month Momentum % | -17.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 723.96 | |||||
| Days Sales Outstanding | 39.46 | |||||
| Days Payable | 19.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.2 | |||||
| Shareholder Yield % | -1.29 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.62 | |||||
| Operating Margin % | -88.55 | |||||
| Net Margin % | -93.8 | |||||
| FCF Margin % | -74.5 | |||||
| ROE % | -91.36 | |||||
| ROA % | -50.36 | |||||
| ROIC % | -274.56 | |||||
| 3-Year ROIIC % | -82.57 | |||||
| ROC (Joel Greenblatt) % | -430.59 | |||||
| ROCE % | -80.01 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.29 | |||||
| PB Ratio | 0.6 | |||||
| Price-to-Tangible-Book | 0.58 | |||||
| EV-to-EBIT | -0.8 | |||||
| EV-to-EBITDA | -0.8 | |||||
| EV-to-Revenue | 0.71 | |||||
| EV-to-FCF | -0.95 | |||||
| Price-to-GF-Value | 0.05 | |||||
| Price-to-Net-Current-Asset-Value | 0.69 | |||||
| Earnings Yield (Greenblatt) % | -125 | |||||
| FCF Yield % | -69.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NanoVibronix Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.024 | ||
| EPS (TTM) (€) | -0.802 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.33 | ||
| 3-Year Sortino Ratio | -1.44 | ||
| Volatility % | 85.95 | ||
| 14-Day RSI | 41.74 | ||
| 14-Day ATR (€) | 0.026653 | ||
| 20-Day SMA (€) | 0.49095 | ||
| 12-1 Month Momentum % | -17.56 | ||
| 52-Week Range (€) | 0.432 - 1.38 | ||
| Shares Outstanding (Mil) | 3.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NanoVibronix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NanoVibronix Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
NanoVibronix Inc Frequently Asked Questions
What is NanoVibronix Inc(STU:56R0)'s stock price today?
The current price of STU:56R0 is €0.46. The 52 week high of STU:56R0 is €1.38 and 52 week low is €0.43.
When is next earnings date of NanoVibronix Inc(STU:56R0)?
The next earnings date of NanoVibronix Inc(STU:56R0) is 2025-05-15 Est..
Does NanoVibronix Inc(STU:56R0) pay dividends? If so, how much?
NanoVibronix Inc(STU:56R0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers